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The SPA17 gene contains 5 exons and 4 introns and 
was predicted to span over approximately 23 kb of the 
genomic DNA. The first exon is encodes solely the 5' 
untranslated sequence. The exon 2 encodes the first 51 
amino acid residue. Exon 3 and 4 are only 71 and 87 bp 
length and contain coding region. Exon 5 contains stop
codon and followed by 3' untranslated sequence. The 
size of introns 2, 3 and 4 were 5970, 10.235 and 2520 
bp, respectively. 
Transcription 
Two transcript variants encoding the same protein have 
been identified for SP17-1 gene. This variant which 
was named SP17-1A and SP17-1B, both cDNA 
encodes identical protein sequence and only differed in 
5' UTR part. One hundred percent homology can be 
detected from the poly A tail up to SP17-1 position -62 
for variant A and -31 for variant B. 
Pseudogene 
There is one pseudogene, SP17-2 intronless gene has 
all the hallmark of retro-position giving rise to a 
pseudogene, located on chromosome 10. SP17-2 gene 
had 61 point mutations, 4 nucleotide insertions and2 
deletions leading to internal stop codons and frame 
shifts which do not result in ORF encoding a full-





The SPA17 consists of 151 amino acids corresponding 
to a molecular weight of 17.4 kDa. SPA17 protein 
indicated to have functional role in cell regulation by 
its calmodulin binding site located at its C-terminal 
end. The N-terminal end of SPA17, similar to human 
cyclic adenosine 3'-5'-monophosphate (cAMP)-
dependent protein kinase type II regulatory subunits 
(RII), may facilitate dimmer formation. SPA17's 
central domain is necessary for heparin-binding and
exhibits the greatest sequence divergence of all three 
domains. This region plays an important role in cell-
cell and/or cell matrix recognition process and/or cell 
regulation, possibly via its interaction with extra 
cellular heparin sulfate. 
Expression 
The SPA17 expression was originally found to be 
expressed exclusively in the testis. Recently, this gene 
also found in other somatic tissues. 
Localisation 
SPA17 is present throughout the cytoplasm and is 
particularly concentrated around the nucleus. It's also 
present on the surface of B-lymphocytes and 
granulocytes; T-lymphocytes and monocytes; most 
malignant B and T lymphocytes cell lines. 
Function 
SPA17 is highly antigenic, testes specific antigen and 
known have function to bind sperm to the zona 
pellucida of the oocyte. In addition, SPA17 may also 
have an alternative role in highly proliferating and 
neoplastic cells, such as a mediator of signal 
transduction, protein synthesis and/or unregulated 
growth. 
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Homology 
The homologues of SPA17 protein sequences were 
found from eutherian and marsupial mammals, 
including rat, mouse, macaque, baboon, human, 




SPA17 is a highly immunogenic protein. More than 
90% of male spontaneously developed B-cell immunity 
of SPA17 following vasectomy. SPA17 can be easily 
generated SPA17-specific cytotoxic T lymphocytes 
(CTLs) from peripheral blood of healthy donors and 
also from peripheral blood of cancer-bearing patients. 
SPA17 have been tested as tumor vaccines in a phase I 
study. In addition, SPA17 gene was described in human 
rheumatoid arthritis (RA). 
Malignancy 
Disease 
SPA17 reported to be over-expressed in female 
reproduction organ, multiple myeloma, 
esthesioneuroblastoma, nervous system tumors  and 
esophageal cancer. 
Prognosis 
SPA17 expression closely related with poor prognosis 
in malignancy. 
Oncogenesis 
SPA17 was identified as a candidate gene related to 
chemoresistance of clear cell adenocarcinoma of the 
ovary, which has a poor prognosis due to its 
chemoresistancy and early metastasis to the lymph 
nodes. 
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